These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18193190)

  • 1. Autoantibodies to IA-2beta improve diabetes risk assessment in high-risk relatives.
    Achenbach P; Bonifacio E; Williams AJ; Ziegler AG; Gale EA; Bingley PJ;
    Diabetologia; 2008 Mar; 51(3):488-92. PubMed ID: 18193190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
    Dittler J; Seidel D; Schenker M; Ziegler AG
    Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk.
    Bingley PJ; Gale EA;
    Diabetologia; 2006 May; 49(5):881-90. PubMed ID: 16514546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
    Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
    Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives.
    Maclaren N; Lan M; Coutant R; Schatz D; Silverstein J; Muir A; Clare-Salzer M; She JX; Malone J; Crockett S; Schwartz S; Quattrin T; DeSilva M; Vander Vegt P; Notkins A; Krischer J
    J Autoimmun; 1999 Jun; 12(4):279-87. PubMed ID: 10330299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of autoantibodies to zinc transporter 8 in prediction of type 1 diabetes in relatives: lessons from the European Nicotinamide Diabetes Intervention Trial (ENDIT) cohort.
    Long AE; Gooneratne AT; Rokni S; Williams AJ; Bingley PJ
    J Clin Endocrinol Metab; 2012 Feb; 97(2):632-7. PubMed ID: 22162482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic markers for the development of type 1 diabetes in first-degree relatives of diabetic patients.
    Siewko K; Popławska-Kita A; Telejko B; Maciulewski R; Zielińska A; Nikołajuk A; Górska M; Szelachowska M
    Endokrynol Pol; 2014; 65(3):176-80. PubMed ID: 24971917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT).
    Bingley PJ; Mahon JL; Gale EA;
    Diabetes Care; 2008 Jan; 31(1):146-50. PubMed ID: 17959864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
    Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
    Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives.
    Pastore MR; Bazzigaluppi E; Bonfanti R; Dozio N; Sergi A; Balini A; Belloni C; Meschi F; Bonifacio E; Bosi E
    Diabetes Care; 1998 Sep; 21(9):1445-50. PubMed ID: 9727889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.
    Decochez K; Truyen I; van der Auwera B; Weets I; Vandemeulebroucke E; de Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Pipeleers DG; Gorus FK;
    Diabetologia; 2005 Apr; 48(4):687-94. PubMed ID: 15756536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and fasting plasma glucose in first degree relatives of patients with type 1 diabetes.
    Siewko K; Popławska-Kita A; Telejko B; Maciulewski R; Zielińska A; Nikołajuk A; Górska M; Szelachowska M
    J Diabetes Complications; 2013; 27(6):593-6. PubMed ID: 23890682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
    Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
    Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population.
    Kimpimäki T; Kulmala P; Savola K; Kupila A; Korhonen S; Simell T; Ilonen J; Simell O; Knip M
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4572-9. PubMed ID: 12364437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group.
    Seissler J; Atik Y; Klinghammer A; Scherbaum WA
    Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics.
    Achenbach P; Warncke K; Reiter J; Naserke HE; Williams AJ; Bingley PJ; Bonifacio E; Ziegler AG
    Diabetes; 2004 Feb; 53(2):384-92. PubMed ID: 14747289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose tolerance and beta-cell function in islet autoantibody-positive children recruited to a secondary prevention study.
    Andersson C; Carlsson A; Cilio C; Cedervall E; Ivarsson SA; Jonsdottir B; Jönsson B; Larsson K; Neiderud J; Lernmark A; Elding Larsson H;
    Pediatr Diabetes; 2013 Aug; 14(5):341-9. PubMed ID: 23469940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials.
    Bingley PJ; Williams AJ; Gale EA
    Diabetes Care; 1999 Nov; 22(11):1796-801. PubMed ID: 10546010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IA-2 autoantibodies predict impending type I diabetes in siblings of patients.
    Decochez K; De Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Weets I; Vandemeulebroucke E; Truyen I; Kaufman L; Schuit FC; Pipeleers DG; Gorus FK;
    Diabetologia; 2002 Dec; 45(12):1658-66. PubMed ID: 12488955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of autoantibody markers and risk for development of type 1 diabetes: results from a large french cohort of family members.
    Thivolet C; Nicolino M; Monbeig S; Estour B; Halimi S; Robert M; Orgiazzi J; Chatelain P;
    Diabetes Metab; 2002 Sep; 28(4 Pt 1):279-85. PubMed ID: 12442065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.